Fri Jan 30 First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients Written by PR Newswire Asia - News Pronto RSS Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4873824_AE73824_0
